Sanjay Divakaran

ORCID: 0000-0003-0598-6502
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cardiac Imaging and Diagnostics
  • Cardiovascular Function and Risk Factors
  • Acute Myocardial Infarction Research
  • Sarcoidosis and Beryllium Toxicity Research
  • Cardiovascular Disease and Adiposity
  • Lipoproteins and Cardiovascular Health
  • Peripheral Artery Disease Management
  • Systemic Lupus Erythematosus Research
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Atherosclerosis and Cardiovascular Diseases
  • Vasculitis and related conditions
  • Chemotherapy-induced cardiotoxicity and mitigation
  • Cardiac Structural Anomalies and Repair
  • Advanced MRI Techniques and Applications
  • Cardiac Arrhythmias and Treatments
  • Heart Failure Treatment and Management
  • Viral Infections and Immunology Research
  • Cardiac, Anesthesia and Surgical Outcomes
  • Cardiovascular Effects of Exercise
  • Cardiovascular Health and Risk Factors
  • Cardiac Health and Mental Health
  • Diversity and Career in Medicine
  • Cardiovascular Issues in Pregnancy
  • Cardiac Valve Diseases and Treatments
  • Diagnosis and Treatment of Venous Diseases

Brigham and Women's Hospital
2015-2025

Harvard University
2015-2025

Massachusetts General Hospital
2025

Beth Israel Deaconess Medical Center
2022-2023

Cedars-Sinai Medical Center
2023

Mass General Brigham
2023

Deaconess Hospital
2022

National Institutes of Health
2020

ORCID
2020

University of Massachusetts Boston
2019

Lauren A. Eberly Aaron Richterman Anne G. Beckett Bram Wispelwey Regan H. Marsh and 95 more Emily Cleveland Cindy Y. Chang Robert J. Glynn Katherine Brooks Robert Boxer Rose M. Kakoza Jennifer Goldsmith Joseph Loscalzo Michelle Morse Eldrin F. Lewis Samantha Abel Ayrenne Adams Joseph Anaya Erik Andrews Benjamin Atkinson Viswatej Avutu Alexandra E. Bachorik Omar Badri Mariel Bailey Katie Baird Dellara F. Terry Denis Balaban Kenneth Barshop Emily Baumrin Omar Bayomy Julia Beamesderfer Nora V. Becker David D. Berg Berman Adam N. Steven M. Blum Alexander P. Boardman Kaeleen A. Boden Robert A. Bonacci Sarah Brown Kirsti Campbell Siobhan M. Case Emily Cetrone Alexandra Charrow David J. Chiang Devin Clark Aarón Cohen A. Feder Cooper Tomas Cordova C. Nicholas Cuneo Alsina Alejandro de Feria Karen Deffenbacher Ersilia M. DeFilippis Geneva DeGregorio Aaron J. Deutsch Bradford Diephuis Sanjay Divakaran Peter B. Dorschner Nicholas S. Downing Caitlin Drescher Kristin M. D’Silva Peter J. Dunbar David Duong Sarah E. Earp Christine Eckhardt Scott A. Elman Ross England Kay Everett Natalie O. Fedotova Tamara Feingold-Link Mark Ferreira H. Russell Fisher Patricia K. Foo Michael B. Foote Idalid Franco Thomas Gilliland Jacqueline Greb Katherine J. Greco Sungat K. Grewal Benjamin Grin Matthew E. Growdon Brendan J. Guercio Cynthia K. Hahn Brian W. Hasselfeld Erika J Haydu Zachary Hermes Gordon J. Hildick-Smith Zachary E. Holcomb Kathryn B. Holroyd Laura Horton George T.‐J. Huang Stanley Jablonski Douglas Jacobs Nina Jain Sohan Japa Richard Joseph Mariya Kalashnikova Neil Kalwani Daniel G. Kang Abraar Karan Joel T. Katz

Background: Racial inequities for patients with heart failure (HF) have been widely documented. HF who receive cardiology care during a hospital admission better outcomes. It is unknown whether there are differences in to or general medicine service by race. This study examined the relationship between race and service, its effect on 30-day readmission mortality Methods: We performed retrospective cohort from September 2008 November 2017 at single large urban academic referral center of all...

10.1161/circheartfailure.119.006214 article EN Circulation Heart Failure 2019-10-29

Abstract Background and Aims Skeletal muscle (SM) fat infiltration, or intermuscular adipose tissue (IMAT), reflects quality is associated with inflammation, a key determinant in cardiometabolic disease. Coronary flow reserve (CFR), marker of coronary microvascular dysfunction (CMD), independently body mass index (BMI), inflammation risk heart failure, myocardial infarction, death. The relationship between SM quality, CMD, cardiovascular outcomes not known. Methods Consecutive patients (n =...

10.1093/eurheartj/ehae827 article EN other-oa European Heart Journal 2025-01-20

BACKGROUND: Preeclampsia is a pregnancy-specific hypertensive disorder associated with an imbalance in circulating proangiogenic and antiangiogenic proteins. Preclinical evidence implicates microvascular dysfunction as potential mediator of preeclampsia-associated cardiovascular risk. METHODS: Women singleton pregnancies complicated by severe antepartum-onset preeclampsia comparator group normotensive deliveries underwent cardiac positron emission tomography within 4 weeks delivery. A...

10.1161/hypertensionaha.124.22905 article EN Hypertension 2024-04-02

Background: The diagnostic yield of cardiac sarcoidosis (CS) by endomyocardial biopsy is limited. Fluorodeoxyglucose (FDG) positron emission tomography (PET) and magnetic resonance imaging (MRI) may facilitate noninvasive diagnosis, but the accuracy this approach not well defined. We aimed to correlate findings from FDG PET MRI with histological explanted hearts patients who underwent transplantation. Methods: analyzed heart histology for all transplant at our center April 2008 July 2018 had...

10.1161/circimaging.118.008975 article EN Circulation Cardiovascular Imaging 2019-06-01

Background: Cardiac dysfunction and cardiovascular events are prevalent among patients with chronic kidney disease without overt obstructive coronary artery disease, but the mechanisms remain poorly understood. Coronary microvascular has been proposed as a link between abnormal renal function impairment of cardiac events. We aimed to investigate relations dysfunction, adverse outcomes. Methods: Patients undergoing stress positron emission tomography, echocardiogram, ascertainment at Brigham...

10.1161/circulationaha.119.043916 article EN Circulation 2019-11-29

Abstract Aims Hypertension is a well-established heart failure (HF) risk factor, especially in the context of adverse left ventricular (LV) remodelling. We aimed to use myocardial flow reserve (MFR) and global longitudinal strain (GLS), markers subclinical microvascular dysfunction, refine hypertensive HF assessment. Methods results Consecutive patients undergoing symptom-prompted stress cardiac positron emission tomography (PET)-computed transthoracic echocardiogram within 90 days without...

10.1093/eurheartj/ehaa191 article EN European Heart Journal 2020-03-06

<h3>Importance</h3> Despite significant progress in primary prevention, the rate of myocardial infarction (MI) continues to increase young adults. <h3>Objectives</h3> To identify prevalence tobacco use and examine association both smoking cessation with survival a cohort adults who experienced an initial MI at age. <h3>Design, Setting, Participants</h3> The Partners YOUNG-MI registry is retrospective study from 2 large academic centers Boston, Massachusetts, that includes patients 50 years...

10.1001/jamanetworkopen.2020.9649 article EN cc-by-nc-nd JAMA Network Open 2020-07-08

Socioeconomic disadvantage is associated with poor health outcomes. However, whether socioeconomic factors are post-myocardial infarction (MI) outcomes in younger patient populations unknown.To evaluate the association of neighborhood-level long-term among patients who experienced an MI at a young age.This cohort study analyzed Mass General Brigham YOUNG-MI Registry (at and Women's Hospital Massachusetts Boston, Massachusetts) or before 50 years age between January 1, 2000, April 30, 2016....

10.1001/jamacardio.2021.0487 article EN JAMA Cardiology 2021-05-19

BACKGROUND: Advanced chronic kidney disease is associated with high cardiovascular risk, even after transplant. Pretransplant cardiac testing may identify patients who require additional assessment before transplant or would benefit from risk optimization. The objective of the current study was to determine relative prognostic utility pretransplant positron emission tomography (PET) and single-photon computed (SPECT) myocardial perfusion imaging (MPI) for posttransplant major adverse events...

10.1161/circimaging.123.015858 article EN Circulation Cardiovascular Imaging 2024-01-01

Lipoprotein (a) [Lp(a)] is a robust predictor of coronary heart disease outcomes, with targeted therapies currently under investigation. We aimed to evaluate the association high Lp(a) standard modifiable risk factors (SMuRFs) for incident first acute myocardial infarction (AMI).

10.1161/jaha.123.034493 article EN cc-by-nc-nd Journal of the American Heart Association 2024-05-18
Coming Soon ...